Breakthrough In Liver Cirrhosis Treatment: Indian Scientists Develop New Approach
Chronic liver disease can progress from mild disease to fibrosis to cirrhosis (also known as scarring).
Cirrhosis is accompanied by the distortion of both blood and lymphatic vessels in the liver and the intestine. Patients with advanced cirrhosis often develop complications like fluid accumulation in the abdomen.
A team of scientists from the Institute of Liver and Biliary Sciences (ILBS), New Delhi, and National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, focussed on improving the drainage capacity of lymphatic vessels in the liver and intestine by using nanocarriers filled with a powerful protein called VEGF-C.
Pic Credits: IANS
'Vascular endothelial growth factor-C (VEGF-C) is a key pro-lymphangiogenic factor that activates lymphangiogenesis or new lymphatic vessel growth. It does this through binding to a cell membrane tyrosine kinase receptor, vascular endothelial growth factor receptor-3 (VEGFR-3), the activation of which is essential for the growth and development of new lymphatic vessels,' said the researchers.
The team probed the therapeutic efficacy of VEGF-C in ameliorating gut lymphatic dysfunction and improving lymph drainage.
Owing to the hydrophilicity, short half-life, and systemic side effects of VEGF-C, the team led by Dr Subham Banerjee from NIPER Guwahati first focused on the development of VEGF-C encapsulated reverse micelle-based nanocarriers, which specifically bind to VEGFR-3 homodimers.
Next, the ILBS team, led by Dr Savneet Kaur, tested the developed VEGF-C nanocarriers extensively in animal models of advanced cirrhosis and portal hypertension.
The developed molecule was delivered via the oral route to ensure its gut lymphatic vessel uptake in the animal models. The team showed that VEGF-C nanocarriers significantly increased mesenteric lymph drainage, which reduced ascites.
Importantly, the treatment also led to an attenuation of the portal pressures, improved cytotoxic T-cell immunity in mesenteric lymph nodes, and reduced local and systemic bacterial load.
The research, published in the JHEP Reports journal, is the first to highlight that therapeutic lymphangiogenesis with VEGF-C is a promising treatment for reconstructing the fragmented lymphatic network and restoring lymphatic function and drainage in advanced cirrhosis.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
5 minutes ago
- Hindustan Times
Lactation specialist says 'breastfeeding requires extra 300–500 calories per day'; shares nutrition tips for new mothers
Mothers who breastfeed know how tough it can be, and it is not because the moms are not trying enough. Often, several mental, environmental, and nutritional factors intervene, making the process, which is beneficial for both the mother and the child, a lot tougher. Breastfeeding typically requires an additional 300–500 calories per day. These should come from healthy, nutrient-rich foods. (Freepik) Also Read | Cardiologist reveals why people in 30s, 40s are collapsing during workouts: Treadmill isn't the enemy but… What new mothers should keep in mind about their nutritional needs Nutrition plays a major role in preparing a mother for her breastfeeding journey. In an interview with HT Lifestyle, Dr Payel Biswas Soo, MS Lact (Spain), IBCLC (USA), a lactation specialist, Milann Hospital, Bengaluru, stressed that breastfeeding mothers have unique nutritional needs to support both their own health and their baby's development. 'Producing breast milk requires extra energy and nutrients, so eating a balanced, nourishing diet is essential during this period,' Dr Biswas stressed. Here are a few key things to keep in mind, as suggested by her: Producing breast milk requires extra energy and nutrients, so eating a balanced, nourishing diet is essential. (Freepik) 1. Increased caloric needs: Breastfeeding typically requires an additional 300–500 calories per day. These should come from healthy, nutrient-rich foods rather than processed or sugary items. Instead of high-sugar or fried snacks, focus on wholesome options like homemade laddoos with nuts, khichdi, roasted makhana, or fruit with curd. 2. Hydration is key: Adequate fluid intake is essential to maintain milk supply. Mothers should drink plenty of water, buttermilk, coconut water, or jeera/saunf-infused water, especially during summer. 3. Focus on a balanced diet: Traditional Indian meals can be highly nutritious. Therefore, in their diet, mothers should include: Proteins: Moong dal, toor dal, eggs, chicken, fish, paneer Whole grains: Brown rice, millets (ragi, bajra), whole wheat chapatis Vegetables: Gourd vegetables, spinach, carrots, pumpkin Healthy fats: Ghee in moderation, nuts, seeds, cold-pressed oils 4. Iron and calcium: Iron-rich foods (like dates, jaggery, and green leafy vegetables) help combat post-delivery fatigue. Calcium is vital for bone health—consume milk, curd, sesame seeds (til) and ragi. 5. Spices and digestives: Indian kitchens offer beneficial spices like ajwain, jeera, haldi, and methi, known to aid digestion and milk production. However, spicy and oily foods should be consumed in moderation to prevent discomfort for both mother and baby. 6. Traditional foods: Postpartum foods like panjiri, halim (garden cress seeds), and gond laddoo can be nourishing but should be homemade and portion-controlled. 7. Supplements: Doctors may recommend iron, calcium, or vitamin D supplements depending on dietary intake and blood levels. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Economic Times
5 minutes ago
- Economic Times
Novo Nordisk's Wegovy, Mounjaro sales in India double on month in July
Synopsis Sales of Novo Nordisk's Wegovy and Eli Lilly's Mounjaro in India doubled in July, according to Pharmarack data. Wegovy, launched in June, saw sales more than double to 5,000 units, while Mounjaro sales also doubled to 157,000 units. Mounjaro's sales have soared 15 times since its March launch in India. IANS Representational Image Sales of Danish drugmaker Novo Nordisk's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month earlier, data from research firm Pharmarack showed on Thursday. Demand for the blockbuster anti-obesity drugs, which help control blood sugar and slow digestion, has been on an upswing in the world's most populous nation. Sales of Wegovy, launched locally in June, more than doubled to 5,000 units or 70 million rupees ($798,230) in July, the data showed. Mounjaro sales also doubled month-on-month to 157,000 units or 470 million rupees. "Though Wegovy has a strong prescriber base because of Rybelsus, substantial promotion may be needed to reach the Mounjaro patient base for the injectable market," Pharmarack's Vice President (Commercial) Sheetal Sapale said in a statement. In India, Novo has been selling oral semaglutide pills under the brand name Rybelsus since 2022 for type 2 diabetes. Mounjaro's sales have soared 15 times since March, when the drug was launched in India. ($1 = 87.6790 Indian rupees)
Time of India
33 minutes ago
- Time of India
Indian space startup Agnikul builds world's largest single-piece 3D-printed Inconel rocket engine, granted a patent in US
Indian space startup Agnikul Cosmos has achieved a significant milestone by building the world's largest single-piece 3D-printed Inconel rocket engine made from Inconel, a high-performance superalloy known for its strength and heat resistance. Tired of too many ads? go ad free now This breakthrough engine, about a meter long, is printed entirely as one integrated component without any welds, joints, or fasteners from fuel entry to plume exit. Such an innovation drastically reduces manufacturing complexity, production time, and potential failure points, positioning Agnikul at the forefront of additive manufacturing in rocketry. Further elevating their accomplishment, Agnikul has been granted a US patent for the design and manufacturing process of this single-piece rocket engine. Being granted a patent in the US means that Agnikul holds exclusive legal rights to their invention within one of the world's largest and most competitive markets, preventing others from making, using, or selling the patented technology without permission. This patent marks a rare achievement for an Indian-origin design, reflecting the startup's growing influence in global space technology and reinforcing India's position in the next-generation rocket manufacturing landscape. Agnikul revolutionising rocket manufacturing with single-piece 3D printing Agnikul Cosmos' engine represents a major leap in aerospace engineering, leveraging additive manufacturing technology to print a complete rocket engine as a single piece. This method eliminates the need for traditional assembly processes, which often involve complex welding and joining of multiple parts. The use of Inconel, a nickel-chromium-based superalloy, ensures that the engine can withstand the extreme temperatures and pressures encountered during rocket launches. Tired of too many ads? go ad free now The scale and complexity of this engine surpass earlier models, allowing more efficient fluid flow and improved durability. This fully integrated manufacturing approach cuts down production time by over 60% and reduces weight, enhancing the overall performance and cost-effectiveness of rockets. Agnikul's innovation is a clear example of how advanced 3D printing is revolutionizing space technology, making rocket production faster, safer, and more scalable. Strategic impact and support from Indian space ecosystem The US patent granted to Agnikul Cosmos is a significant intellectual property victory that underscores the originality and technical sophistication of their design. The patent provides legal protection in a highly competitive global market historically dominated by established aerospace giants. This milestone strengthens India's position in the private space sector and signals growing confidence in indigenous technologies. Agnikul's progress is supported by collaborations with key Indian space institutions, including and INSPACe, as well as partnerships with industry leaders like Wipro 3D. Government backing through agencies like the Department of Science and Technology (DST) and the Technology Development Board (TDB) has been instrumental in fostering innovation. This collective effort is driving India's emergence as a leader in next-generation rocket propulsion and space exploration technologies.
